诱导多能干细胞巨噬细胞向供者匹配的胰岛浸润T细胞TCR呈递胰岛素原抗原
该研究将1型糖尿病供者来源的诱导多能干细胞(iPSC)分化为CD14+巨噬细胞,检测其向同一供者胰岛浸润CD4+ T细胞来源的T细胞受体(TCR)呈递抗原的能力。iPSC巨噬细胞具有典型巨噬细胞形态、表面标志和吞噬功能,经IFNγ处理后上调HLA II类分子,并能向表达供者胰岛浸润CD4+ T细胞TCR的T细胞系呈递胰岛素原C肽表位,该激活可被抗HLA-DQ抗体特异性阻断而不被抗HLA-DR抗体阻断。研究为利用iPSC来源免疫细胞模拟人类1型糖尿病关键细胞相互作用提供了概念验证。
要点
- iPSC可分化为具有典型形态、表面标志和吞噬功能的CD14+巨噬细胞。
- IFNγ处理上调iPSC巨噬细胞HLA II类分子,与其抗原呈递能力相关。
- 抗原呈递激活T细胞可被抗HLA-DQ而非抗HLA-DR抗体阻断。
核心结论
- 研究为利用iPSC来源免疫细胞模拟人类1型糖尿病关键细胞相互作用提供了概念验证。
研究设计与样本
- 将1型糖尿病死亡器官供者来源的iPSC系分化为CD14+巨噬细胞,并检测其向同一供者胰岛浸润CD4+ T细胞来源的TCR呈递抗原的能力。
主要发现
- iPSC巨噬细胞显示典型巨噬细胞形态、表面标志(CD14、CD86、CD16和CD11b)并具有吞噬功能。
- IFNγ处理上调iPSC巨噬细胞HLA II类分子表达,该特征与其向表达供者胰岛浸润CD4+ T细胞TCR的T细胞系呈递胰岛素原C肽表位的能力相关。
- T细胞激活可被抗HLA-DQ抗体特异性阻断,而不被抗HLA-DR抗体阻断。
临床怎么用
- 该模型可用于研究1型糖尿病中巨噬细胞与自身反应性T细胞的相互作用及HLA-DQ限制性抗原呈递。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 1 diabetes is an autoimmune disorder characterised by loss of insulin-producing beta cells of the pancreas. Progress in understanding the cellular and molecular mechanisms underlying the human disease has been hampered by a dearth of appropriate human experimental models. We previously reported the characterisation of islet-infiltrating CD4+ T cells from a deceased organ donor who had type 1 diabetes. METHODS: Induced pluripotent stem cell (iPSC) lines derived from the above donor were differentiated into CD14+ macrophages and tested for their capacity to present antigen to T cell receptors (TCRs) derived from islet-infiltrating CD4+ T cells from the same donor. RESULTS: The iPSC macrophages displayed typical macrophage morphology, surface markers (CD14, CD86, CD16 and CD11b) and were phagocytic. In response to IFNγ treatment, iPSC macrophages upregulated expression of HLA class II, a characteristic that correlated with their capacity to present epitopes derived from proinsulin C-peptide to a T cell line expressing TCRs derived from islet-infiltrating CD4+ T cells of the original donor. T cell activation was specifically blocked by anti-HLA-DQ antibodies but not by antibodies directed against HLA-DR. CONCLUSIONS/INTERPRETATION: This study provides a proof of principle for the use of iPSC-derived immune cells for modelling key cellular interactions in human type 1 diabetes.
引用
- Joshi K, Elso C, Motazedian A, et al. Induced pluripotent stem cell macrophages present antigen to proinsulin-specific T cell receptors from donor-matched islet-infiltrating T cells in type 1 diabetes. Diabetologia. 2019. PMID: 31511930. doi:10.1007/s00125-019-04988-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。